Home » Topics » Regulatory » Patents

Patents
RSS

New deuterium-enriched eszopiclone analogues reported for insomnia in recent Protia patent

Feb. 24, 2009

New mTOR kinase inhibtors reported in recent AstraZeneca patents

Feb. 24, 2009

PanThera divulges new anthrax lethal factor inhibitors

Feb. 23, 2009

Novel neuraminidase inhibitors for treating influenza prepared at Hokkaido University

Feb. 23, 2009

New histamine H3 receptor antagonists for treatment of AD reported by Wyeth

Feb. 23, 2009

Kyowa Hakko Kirin reports prostanoid FP receptor agonists with antiglaucoma properties

Feb. 23, 2009

New P2Y12 receptor antagonists claimed by sanofi-aventis for thrombotic disorders

Feb. 23, 2009

BMS scientists report new dual-action NK-1 antagonists/5-HT reuptake inhibitors

Feb. 23, 2009

GSK claims novel PI3Kalpha inhibitors with potential as anticancer agents

Feb. 23, 2009

Sanofi-aventis scientists describe new anticancer Hsp90 inhibitors in recent patent

Feb. 23, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...